By David Sachs Ipsen shares rose Thursday after the French pharmaceutical firm raised its 2023 outlook. At 0749 GMT, Ipsen shares were up 4% to EUR114.50..
By Giulia Petroni The European Medicines Agency has recommended the approval of Ipsen's Bylvay treatment for cholestatic pruritus in patients with Alagille.
By Pierre Bertrand Ipsen said on Wednesday that the European Commission has decided against granting a marketing authorization for palovarotene for the.